Background: Kaposi's sarcoma (KS) is an indolent angio-proliferative tumor proliferation with spindle cells originating from endothelial and immune cells infected with human herpes virus type 8. (HHV-8: also known as Kaposi sarcoma herpes virus [KSHV]). HHV-8 was identified as the causative agent of KS. This virus is present in 95-98% of cases with KS. Kaposi's sarcoma was first described by a Hungarian dermatologist 1872 named Moritz Kaposi.
The lesions are characterized by the proliferation of spindle cells of endothelial origin, which present different degrees of abnormal vascularization, inflammatory infiltrates, and fibrosis. Kaposi's Sarcoma (KS) is a malignancy that generally affects the skin, and can be systemic with internal organ involvement. It originates from the vascular endothelium. KS's relationship with human immunodeficiency virus (HIV) infection is well known.
In this article, we will present a 73-year-old male patient with 3 purple scrotal lesions up to 0.5 cm in size.
Conclusion; Kaposi's sarcoma of the scrotum in a negative patient is a rare pathology. However, in cases of scrotal lesions that last over time, a differential diagnosis should be made and Kaposi's sarcoma should be taken into consideration. Also, a screening for other accompanying lesions, especially a detailed examination of the gastrointestinal tract is important in cases of Kaposi’s sarcoma of the scrotum.
Braun M. Classics in Oncology. Idiopathic multiple pigmented sarcoma of the skin by Kaposi. CA Cancer J Clin. 1982 Nov-Dec;32(6):340-7. doi: 10.3322/canjclin.32.6.340. PMID: 6812893.
Rescigno P, Di Trolio R, Buonerba C, De Fata G, Federico P, Bosso D, Virtuoso A, Izzo M, Policastro T, Vaccaro L, Cimmino G, Perri F, Matano E, Delfino M, De Placido S, Palmieri G, Di Lorenzo G. Non-AIDS-related Kaposi's sarcoma: A single-institution experience. World J Clin Oncol. 2013 May 10;4(2):52-7. doi: 10.5306/wjco.v4.i2.52. PMID: 23696963; PMCID: PMC3659264.
DeVita V. AIDS-related malignancies. DeVita V, Vincent T Jr, eds. Cancer: Principles and Practice of Clinical Oncology. 5th ed. Philadelphia, Pa: Lippincott, Williams, & Wilkins; 2008. Vol 8: 2404-2407.
Duprez R, Lacoste V, Brière J, Couppié P, Frances C, Sainte-Marie D, et al. Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. J Natl Cancer Inst. 2007 Jul 18. 99(14):1086-94.
Paulose-Murphy M, Ha NK, Xiang C, Chen Y, Gillim L, Yarchoan R, et al. Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). J Virol. 2001 May. 75(10):4843-53.
Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, HIV/AIDS Cancer Match Study. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007 Jun 20. 99 (12):962-72..
Brown EE, Whitby D, Vitale F, et al. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer. 2006 Nov 1. 107(9):2282-90.
Schwartz RA, Micali G, Nasca MR, Scuderi L. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol 2008; 59:179-208. [CrossRef]
Vyas S, Manabe T, Herman JR, Newman HR. Kaposi's sarcoma of scrotum. Urology. 1976 Jul;8(1):82-5. doi: 10.1016/0090-4295(76)90063-7. PMID: 945927.
Ozmen H, Baba D, Kacagan C, Kayikci A, Cam K. Case report: HIV negative isolated scrotal Kaposi's sarcoma. Int J Surg Case Rep. 2014;5(12):1086-7. doi: 10.1016/j.ijscr.2014.11.019. Epub 2014 Nov 13. PMID: 25460481; PMCID: PMC4275971.
The Egyptian Journal of Hospital Medicine (January 2018) Vol. 70 (5), Page 801-805
Yenice MG, Varnalı E, Şeker KG, Kavak A, Tuğcu V. Scrotal Kaposi's Sarcoma in HIV-negative patient: A case report and review of the literature. Turk J Urol. 2018 Mar;44(2):182-184. doi: 10.5152/tud.2017.68366. Epub 2017 Dec 11. PMID: 29511591; PMCID: PMC5832383.
Al Aboud D. Scrotal Kaposi’s sarcoma in an immunocompetent patient: A case report and review of the literature. Our Dermatol Online. 2022;13(e):e57.
Stratigos AJ, Malanos D, Touloumi G, et al. Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers. Arch Dermatol. 2005 Nov. 141(11):1421-6.
Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013 Feb;137(2):289-94. doi: 10.5858/arpa.2012-0101-RS. PMID: 23368874.
Balachandra B, Tunitsky E, Dawood S, Hings I, Marcus VA. Classic Kaposi's sarcoma presenting first with gastrointestinal tract involvement in a HIV-negative Inuit male--a case report and review of the literature. Pathol Res Pract. 2006;202(8):623-6. doi: 10.1016/j.prp.2006.03.002. Epub 2006 May 8. PMID: 16682127.
Whisman M, Gardner JM. Kaposi sarcoma. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/softtissuekaposi.html. Accessed October 23rd, 2022.
Uccini S, Ruco LP, Monardo F, Stoppacciaro A, et al. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol. 1994 May. 173(1):23-31.
Kimball LE, Casper C, Koelle DM, Morrow R, Corey L, Vieira J. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma. J Infect Dis. 2004 Jun 1. 189(11):2016-22.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.